Jane Street’s Satellos Bioscience MSLE Stock Holding History

Jane Street’s Portfolio MSLE Stock Details MSLE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,608	Closed	-$110K	–	13822
2026 Q1	$110K	Buy	+19,608	New	+$193K	﹤0.01%	10590

Other funds holding MSLE

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Jane Street's MSLE Position: Q2 2026 in Review

Jane Street sold out of Satellos Bioscience (MSLE) in Q2 2026, closing a stake of 19,608 shares — an estimated $110K sold.

Jane Street first reported a position in MSLE in Q1 2026 and held it in 1 quarter. The position peaked at $110K in Q1 2026. 26 funds tracked by Wall St. Rank hold MSLE as of Q2 2026.

Jane Street reported no remaining Satellos Bioscience position as of Q2 2026 after selling out during the quarter.
Jane Street sold 19,608 Satellos Bioscience shares in Q2 2026, an estimated $110K.
Jane Street first reported a position in Satellos Bioscience in Q1 2026 and held it in 1 quarter.
Jane Street's Satellos Bioscience position peaked at $110K in Q1 2026.
26 funds tracked by Wall St. Rank held Satellos Bioscience as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.